Tetrault Lynn A.

Tetrault Lynn A. is listed in filings as Director at Rhythm Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2026, including purchase activity. Recent filings connect the profile to Rhythm Pharmaceuticals, Inc. (RYTM), Acelyrin, Inc. (SLRN), NeoGenomics, Inc. - Common Stock (NEO), and Alumis Inc. Common Stock (ALMS). The current snapshot covers public activity from Aug 13, 2024 to Jun 25, 2026. Reported amounts are shown as $397.0K to $655.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.